Literature DB >> 8376413

Structural prerequisites for serum amyloid A fibril formation.

M C de Beer1, F C de Beer, W D McCubbin, C M Kay, M S Kindy.   

Abstract

Most studies of experimental amyloid A protein (AA) amyloidosis in mice have been performed in type A mice with BALB/c as the prototype. In these mice the products of two genes, SAA1 and SAA2, are the major apo-SAA isoforms on high density lipoprotein (HDL). Of these two isoforms, that differ at nine amino acids, only apo-SAA2 is rapidly cleared and deposited as amyloid fibrils. No mouse strain has ever been shown to be completely resistant to amyloid induction. We have found the CE/J mouse strain to be exceedingly resistant to amyloidogenesis. Data indicate that this resistance is not due to a lack of apo-SAA synthesis but rather resides in the unique apo-SAA isoform in this strain. CE/J mice have a single major apo-SAA isoform (pI 6.15) the product of a single gene. This is a hybrid molecule with features of both apo-SAA1 and apo-SAA2, differing from the latter at only six amino acids. When CD studies were performed to explore the structural relationship of this isoform to apo-SAA1 and apo-SAA2, we found that when bound to heparan sulfate proteoglycan the CE/J pI 6.15 isoform fails to undergo the beta-sheet folding typical for apo-SAA2. This evidence suggests that the folding effect of heparan sulfate proteoglycan on apo-SAA2 is important in amyloid formation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8376413

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Inflammation protein SAA2.2 spontaneously forms marginally stable amyloid fibrils at physiological temperature.

Authors:  Zhuqiu Ye; Diane Bayron Poueymiroy; J Javier Aguilera; Saipraveen Srinivasan; Yun Wang; Louise C Serpell; Wilfredo Colón
Journal:  Biochemistry       Date:  2011-10-05       Impact factor: 3.162

Review 2.  Anti-amyloid drugs: potential in the treatment of diseases associated with aging.

Authors:  R Kisilevsky
Journal:  Drugs Aging       Date:  1996-02       Impact factor: 3.923

3.  A cell culture system for the study of amyloid pathogenesis. Amyloid formation by peritoneal macrophages cultured with recombinant serum amyloid A.

Authors:  B Kluve-Beckerman; J J Liepnieks; L Wang; M D Benson
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

4.  Impact of individual acute phase serum amyloid A isoforms on HDL metabolism in mice.

Authors:  Myung-Hee Kim; Maria C de Beer; Joanne M Wroblewski; Richard J Charnigo; Ailing Ji; Nancy R Webb; Frederick C de Beer; Deneys R van der Westhuyzen
Journal:  J Lipid Res       Date:  2016-03-27       Impact factor: 5.922

5.  SAA does not induce cytokine production in physiological conditions.

Authors:  Myung-Hee Kim; Maria C de Beer; Joanne M Wroblewski; Nancy R Webb; Frederick C de Beer
Journal:  Cytokine       Date:  2012-11-17       Impact factor: 3.861

6.  Mouse serum amyloid A (SAA) proteins isolated by two-dimensional electrophoresis: characterization of isotypes and the effect of separate and combined administrations of cytokines, dexamethasone and lipopolysaccharide (LPS) on serum levels and isotype distribution.

Authors:  C Foyn Bruun; K Sletten; G Marhaug
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

7.  Protein fibrils in nature can enhance amyloid protein A amyloidosis in mice: Cross-seeding as a disease mechanism.

Authors:  Katarzyna Lundmark; Gunilla T Westermark; Arne Olsén; Per Westermark
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-13       Impact factor: 11.205

8.  Adenoviral expression of murine serum amyloid A proteins to study amyloid fibrillogenesis.

Authors:  M S Kindy; A R King; J Yu; C Gerardot; J Whitley; F C de Beer
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

9.  Kinetic analysis of amyloid formation in the presence of heparan sulfate: faster unfolding and change of pathway.

Authors:  Neda Motamedi-Shad; Elodie Monsellier; Silvia Torrassa; Annalisa Relini; Fabrizio Chiti
Journal:  J Biol Chem       Date:  2009-08-21       Impact factor: 5.157

10.  Expression of recombinant human serum amyloid A in mammalian cells and demonstration of the region necessary for high-density lipoprotein binding and amyloid fibril formation by site-directed mutagenesis.

Authors:  H Patel; J Bramall; H Waters; M C De Beer; P Woo
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.